# Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis

> **NCT00886704** · NA · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 50 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** 500 mg eicosapentaenoic (EPA) plus docosahexaenoic acids (DHA)
- **DIETARY_SUPPLEMENT:** Control convenience drink

## Key facts

- **NCT ID:** NCT00886704
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886704, "Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00886704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*